Viewing Study NCT06083792


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2025-12-27 @ 9:03 AM
Study NCT ID: NCT06083792
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-10-16
First Post: 2023-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ICP Threshold After Decompressive Craniectomy
Sponsor: Tang-Du Hospital
Organization:

Study Overview

Official Title: ICP Threshold of Severe Traunatic Brain Injury After Decompressive Craniectomy
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Severe traumatic brain injury (sTBI) is a critical disease of public health importance. Increased intracranial play a significant role in the secondary injury of TBI. Reducing the ICP is helpful in reducing the mortality of sTBI. The threshold of ICP for sTBI has been suggested. The threshold of ICP for sTBI after decompressive craniectomy is not clear.
Detailed Description: 240 sTBI patients who meet the inclusion criteria will be enrolled in the present study.

All sTBI patients will be screened. If meeting the including criteria, the investigators will contact the family, explain the study, and send a consent form for review.

After obtaining written consent from the family, the ICP and blood pressure will be monitored continuously until retraction of ICP sensor. A mean ICP of each patient will be calculated. The neurological outcome will be assessed at 180 days after injury. A threshold for ICP after decompressive craniectomy will be derived by analyzing the association between mean ICP and neurological outcome.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: